2020 | | A 5-year Retrospective Analysis of Drug Survival, Safety, and Effectiveness of the Infliximab Biosimilar CT-P13 in Patients with Rheumatoid Arthritis and Ankylosing Spondylitis | 서창희 |
2020 | | A peptide derived from the core beta-sheet region of TIRAP decoys TLR4 and reduces inflammatory and autoimmune symptoms in murine models | 서창희 |
2020 | | Roles of Interactions Between Toll-Like Receptors and Their Endogenous Ligands in the Pathogenesis of Systemic Juvenile Idiopathic Arthritis and Adult-Onset Still's Disease | 김지원, 김현아, 서창희, 정주양 |
2020 | | SEASONAL VARIATIONS AND ASSOCIATED FACTORS OF GOUT ATTACKS: A PROSPECTIVE MULTICENTER STUDY IN SOUTH KOREA | 김현아, 서창희, 정주양 |
2020 | | DISEASE ACTIVITY IS IMPORTANT RISK FACTORS FOR MATERNAL AND FETAL OUTCOMES DURING PREGNANCY IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS | 김지원, 김현아, 서창희, 정주양 |
2020 | | COMPARISON OF INFLAMMATORY MARKERS AS DIAGNOSTIC TOOL IN PATIENTS WITH ADULT-ONSET STILL'S DISEASE | 김지원, 김현아, 서창희, 정주양 |
2019 | | The Liver X Receptor Is Upregulated in Monocyte-Derived Macrophages and Modulates Inflammatory Cytokines Based on LXRalpha Polymorphism | 김현아, 서창희, 정주양 |
2019 | | Mindfulness-based cognitive therapy in Korean patients with systemic lupus erythematosus: A pilot study | 김현아, 서창희, 정주양, 조선미 |
2019 | | Body mass index and glucocorticoid dose contribute to subclinical atherosclerosis in Korean patients with systemic lupus erythematosus: A prospective 4 year follow-up study | 김현아, 서창희, 정주양 |
2019 | | Long-term efficacy, safety and immunogenicity in patients with rheumatoid arthritis continuing on an etanercept biosimilar (LBEC0101) or switching from reference etanercept to LBEC0101: an open-label extension of a phase III multicentre, randomised, double-blind, parallel-group study | 서창희 |
2019 | | Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio are associated with disease activity in polymyalgia rheumatica | 김현아, 서창희, 정주양 |
2019 | | Amino acid signatures of HLA Class-I and II molecules are strongly associated with SLE susceptibility and autoantibody production in Eastern Asians | 서창희 |
2019 | | The role of damage-associated molecular pattern for pathogenesis and biomarkers in adult-onset Still's disease | 김현아, 서창희, 정주양 |
2019 | | Rituximab biosimilar CT-P10 for the treatment of rheumatoid arthritis | 김지원, 김현아, 서창희, 정주양 |
2019 | | Neutrophil Extracellular Traps May Contribute to the Pathogenesis in Adult-onset Still Disease | 권지은, 김현아, 서창희, 정주양, 최용준, 한재호 |
2019 | | The Role of Natural Killer Cells in Inflammation in Active Adult-onset Still Disease | 김현아, 정주양 |
2019 | | Effects of tapering tumor necrosis factor inhibitor on the achievement of inactive disease in patients with axial spondyloarthritis: a nationwide cohort study | 김현아 |
2019 | | Biomarkers for adult-onset still's disease: up-to-date | 김현아 |
2019 | | Efficacy and safety of switching from rituximab to biosimilar CT-P10 in rheumatoid arthritis: 72-week data from a randomized Phase 3 trial | 서창희 |
2019 | | Differences in Expression of Human Leukocyte Antigen Class II Subtypes and T Cell Subsets in Behcet's Disease with Arthritis | 김현아, 서창희, 손성향, 정주양 |